Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA commissioner pool, minus one

This article was originally published in The Tan Sheet

Executive Summary

Georgetown University School of Medicine Associate Dean for Clinical Research Raymond Woosley, MD/PhD, has accepted position as dean of University of Arizona College of Medicine beginning this fall. Woosley is understood to have been interviewed by the White House and HHS for post of FDA commissioner the week of June 11 before deciding to accept Arizona position. Woosley's fall from contention for commissioner's spot should come as a relief to dietary supplement advocates; he has been a persistent critic of ephedrine alkaloid-containing products

You may also be interested in...



NDAC Member Wood Joins FDA Commissioner Candidate List

FDA Nonprescription Drug Advisory Committee member and Vanderbilt University Vice Chancellor Alastair Wood, MD, is one of several new candidates for FDA commissioner being considered by the White House

NDAC Member Wood Joins FDA Commissioner Candidate List

FDA Nonprescription Drug Advisory Committee member and Vanderbilt University Vice Chancellor Alastair Wood, MD, is one of several new candidates for FDA commissioner being considered by the White House

NDAC Member Wood Joins FDA Commissioner Candidate List

FDA Nonprescription Drug Advisory Committee member and Vanderbilt University Vice Chancellor Alastair Wood, MD, is one of several new candidates for FDA commissioner being considered by the White House

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092742

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel